ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment for Specific Phobias in Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00051220
Recruitment Status : Completed
First Posted : January 8, 2003
Last Update Posted : June 7, 2013
Sponsor:
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
Thomas H. Ollendick, Virginia Polytechnic Institute and State University

Brief Summary:
This study will compare the effectiveness of three treatments in reducing symptoms of phobia in children and adolescents.

Condition or disease Intervention/treatment Phase
Phobic Disorders Anxiety Disorders Behavioral: One-Session Treatment for Specific Phobias Phase 1 Phase 2

Detailed Description:

Children with specific phobias may experience academic, social, and personal distress, as well as interference in day-to-day activities. One-Session Treatment has been found a rapid and effective treatment for adults with phobic disorders. However, its utility in the treatment of childhood phobia has not been examined.

Participants are randomly assigned to 1 of 3 groups: a one-session treatment group, an education/support group, and a waitlist control group. The one-session treatment group is directly exposed to a phobia object or situation during a 3-hour treatment session. In the education/support group, children are given information about fear and phobias and are taught how to deal with them through workbook activities. Children who participate in the one-session treatment group or the education/support group are assessed 1 week post-treatment and again after 6 months. Participants with improved symptoms have a 1-year follow-up. Participants with phobias that persist at 6 months are encouraged to participate in alternative treatment. Waitlist control participants are assessed pre-treatment and 1 month post-treatment. Those who continue to have phobias at the 1-month assessment are randomly assigned to 1 of the 2 active treatments.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 150 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: One-Session Treatment for Specific Phobias in Children
Study Start Date : October 2001
Actual Primary Completion Date : September 2006
Actual Study Completion Date : September 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety Phobias





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   7 Years to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Primary diagnosis of specific phobia disorder

Exclusion Criteria:

  • Mental retardation
  • Developmental disabilities
  • Suicide threat

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00051220


Locations
United States, Virginia
VA Polytech. Institute and State University
Blacksburg, Virginia, United States
Sweden
University of Stockholm
Stockholm, Sweden
Sponsors and Collaborators
Virginia Polytechnic Institute and State University
National Institute of Mental Health (NIMH)

Responsible Party: Thomas H. Ollendick, Professor, Virginia Polytechnic Institute and State University
ClinicalTrials.gov Identifier: NCT00051220     History of Changes
Other Study ID Numbers: R01MH059308 ( U.S. NIH Grant/Contract )
R01MH059308 ( U.S. NIH Grant/Contract )
DSIR CT-S
First Posted: January 8, 2003    Key Record Dates
Last Update Posted: June 7, 2013
Last Verified: June 2013

Additional relevant MeSH terms:
Disease
Anxiety Disorders
Phobic Disorders
Pathologic Processes
Mental Disorders